Norman Relkin
MD, PhD, Professor at Cornell’s Medical College
Norman Relkin, MD, PhD, is a 23 year faculty member of Cornell’s Medical College (New York, NY), as well as a clinical neurologist and neuroscientist. Dr. Relkin is an internationally recognized expert on Alzheimer’s disease and related disorders. He pioneered the study of naturally occurring human antibodies for the treatment of Alzheimer’s and has over 20 years of experience in design of clinical trials.
Dr. Relkin is a reviewer for the National Institute of Health (NIH) and sits on the editorial board of 3 major scientific journals. Over the last 25 years, Dr. Relkin has authored numerous publications on neurodegenerative and traumatic disorders of the brain.
© Revelis Capital Group 2020
All Rights Reserved.
All Rights Reserved.
Oops! Something went wrong while submitting the form.
RISK DISCLOSURE: Alternative investment products such as private equity and private companies involve a high degree of risk and are speculative investments which are highly illiquid and often have no secondary markets. Private companies are not required to provide periodic pricing or valuation information to investors, are not subject to the same regulatory requirements as public companies or funds. Valuation practices of privately held companies and early stage ventures may not be transparent to investors. An investor could lose all or a substantial amount of his or her investment. There may be restrictions on transferring interests in any private investment. Past performance is not indicative of current or future performance and is not a guarantee. The information provided is as of the date referenced. Securities offered through Great Point Capital, LLC, Member FINRA/SIPC.
NO OFFER OR SOLICITATION: The contents of this website do not constitute an offer of securities or a solicitation of an offer to buy of securities and further the information herein may not be relied upon in making an investment decision related to any investment offering by Revelis Capital Group, Great Point Capital, LLC, or any affiliate, or partner of ("Great Point Capital"). Great Point Capital does not warrant the accuracy or completeness of the information contained herein.
NO OFFER OR SOLICITATION: The contents of this website do not constitute an offer of securities or a solicitation of an offer to buy of securities and further the information herein may not be relied upon in making an investment decision related to any investment offering by Revelis Capital Group, Great Point Capital, LLC, or any affiliate, or partner of ("Great Point Capital"). Great Point Capital does not warrant the accuracy or completeness of the information contained herein.